Athos Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://athostx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects
Phase 1
Completed
- Conditions
- Crohn DiseaseAutoimmune DiseasesInflammatory Bowel DiseasesUlcerative Colitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Athos Therapeutics Inc
- Target Recruit Count
- 76
- Registration Number
- NCT05807971
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
News
No news found